Drug and Medication Industry in Japan: Market Research Reports, Statistics and Analysis

Nabi Biopharmaceuticals - Forward Looking Presentation For Year 2 ...

... For the advanced development, vapendavir (a phase iii-ready human rhinovirus program) nicvax interest pre-clinical programs, including respiratory syncytial virus (rsv), hepatitis c (hcv-nn), broad spectrum ...

Company Report: Drug And Medication In Japan For Year 2012

Company Report: Antiviral In The United States, Japan And Austral ...

... Barda funded there is significant market opportunity for an rsv antiviral treatment us market analysis More than 2.3 Million children ...

Company Report: Drug And Medication In Japan For Year 2012

... Of its innovation pipeline, replacing expired patent by newly invented products (launched 11 drugs over the last three years). It now plans to reinforce its bio genome technology and vaccine business ...

Sbi Holdings Inc. - Company Report For Year 2012

... A drug company engaged in 5-ala businesses under the umbrella of the group, and jointly promote the development of medicine so as to broaden the adaptation of interoperative diagnostic drugs ...

Intercell Ag - Investment Analysis, December 2012

... Approved age groups as soon as possible. In the u.S. The pediatric label extension is currently under review by the fda. In september 2012, intercell S partner biological e. Ltd. Launched the je vaccine ...

Company Report: Smoking Treatment In Australia And Japan For Year ...

... Associated with use of varenicline compared with bupropion for smoking cessation, according to a new study. Published in the british medical journal, the danish research looked data from 35,852 patients (17 ...

Robert Lee - Company Report For Year 2012

... Companies are faced with many challenges such as drug price reductions and market share erosion by multinational companies. Nonetheless, we reiterate our overweight rating on the pharmaceutical sector ...

Drug And Medication Market In Japan

... Nagoya city university (kitani) debiopharm (swiss) ( Yakult) celmoleukin (celeuk) anti-cancer drug (1992) osaka univ. (Taniguchi) takeda ozagrel sodium (cataclt) anti-stroke drug (1988) kyoto univ ...